Start a New Search
SHOWING 41 RESULTS
Boston University behavioral scientist Nina Mazar analyzes different types of public health messaging that could lead to increased vaccination rates, including for COVID-19, in underserved communities in the United States.
University Research | Confronting COVID-19 | Boston UniversityThe exclusion of pregnant patients in initial COVID-19 vaccine clinical trials left many patients and doctors wondering how the vaccine might affect pregnant patients and their unborn babies. But a new Northwestern Medicine study finds the vaccine is not associated with birth defects that are…
University Research | Confronting COVID-19 | Northwestern UniversityVirologist Robert Davey will screen thousands of drugs for effectiveness against COVID-19 infection
Confronting COVID-19 | Boston UniversityAn interdisciplinary team at Northwestern to assess how public thinks, feels and behaves during global pandemic
Confronting COVID-19 | Northwestern UniversityNorthwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19.
Confronting COVID-19 | Northwestern UniversityAcross Boston University’s School of Engineering, researchers are pivoting their work to tackle the many engineering problems associated with the global coronavirus pandemic.
Confronting COVID-19 | Boston UniversityThere may be a way to keep more patients from needing the ICU’s limited space and ventilators. “It’s as simple as flipping on your stomach,” says Boston University researcher
Confronting COVID-19 | Boston UniversityA Boston University researcher studies the effects coronavirus has had on air pollution in cities.
Confronting COVID-19 | Boston UniversityA Boston University researcher plans to survey 1,000 millennials and Generation Zers across the United States, ages 18 to 30, in the coming year (remotely, of course) about the effects of the coronavirus.
Confronting COVID-19 | Boston UniversityResearchers are ramping up production of a promising drug that has proven effective in obliterating SARS-CoV in cellular cultures. The team hopes that the drug might also be effective in the fight against SARS’s close genetic cousin, the novel coronavirus.
Confronting COVID-19 | Northwestern University